Adult Acute Myeloid Leukemia With t(8;21)(q22;q22.1); RUNX1-RUNX1T1

specific

An acute myeloid leukemia (AML) associated with t(8;21)(q22;q22) resulting in RUNX1-RUNX1T1 fusion protein expression. This is seen in 12% of children with AML.

60

Centers

15

Active Trials

Cancer Funding

Top Centers for Adult Acute Myeloid Leukemia With t(8;21)(q22;q22.1); RUNX1-RUNX1T1(60)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
67.7
2
NCI Comprehensive
Active Research Program
67.7
3
NCI Comprehensive
Active Research Program
67.7
4
NCI Comprehensive
Active Research Program
67.7
567.7
6
NCI Comprehensive
Active Research Program
67.7
7
NCI Clinical
Active Research Program
67.7
8
Active Research Program
67.7
9
NCI Comprehensive
Active Research Program
67.7
10
Active Research Program
67.7
11
NCI Comprehensive
Active Research Program
67.7
12
NCI Comprehensive
Active Research Program
67.7
13
Active Research Program
67.7
14
Active Research Program
67.7
15
Active Research Program
67.7
16
NCI Comprehensive
45.2
1745.2
1845.2
19
NCI Comprehensive
45.2
20
NCI Comprehensive
45.2
21
NCI Comprehensive
45.2
22
NCI Comprehensive
45.2
23
NCI Comprehensive
45.2
2445.2
25
NCI Comprehensive
45.2
2645.2
2745.2
2845.2
29
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
45.2
30
NCI Comprehensive
45.2
31
NCI Comprehensive
45.2
32
NCI Comprehensive
45.2
33
NCI Clinical
45.2
34
NCI Comprehensive
45.2
35
NCI Comprehensive
45.2
36
NCI Comprehensive
45.2
3745.2
38
Cedars-Sinai CancerLos Angeles, CA
45.2
39
NCI Comprehensive
45.2
4045.2
4145.2
42
NCI Comprehensive
45.2
43
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
45.2
4445.2
4545.2
46
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
45.2
4745.2
4845.2
4945.2
5045.2
5145.2
5245.2
5345.2
5445.2
5545.2
5645.2
5745.2
5845.2
5945.2
60
BC CancerVancouver, BC
45.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →